{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:01:11Z","timestamp":1793689271418,"version":"4.5.1"},"reference-count":60,"publisher":"Elsevier","isbn-type":[{"value":"9780443346491","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.apha.2025.01.015","type":"book-chapter","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T12:44:03Z","timestamp":1738932243000},"page":"375-391","source":"Crossref","is-referenced-by-count":6,"title":["Innovations in vaccine design: Computational tools and techniques"],"prefix":"10.1016","author":[{"given":"Riya","family":"Nag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchita","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saliha","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Tasleem","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/bs.apha.2025.01.015_bib1","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","article-title":"Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults","volume":"383","author":"Anderson","year":"2020","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"10.1016\/bs.apha.2025.01.015_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s42398-020-00107-z","article-title":"COVID-19 and importance of environmental sustainability","volume":"3","author":"Arora","year":"2020","journal-title":"Journal of Environmental Sustainability"},{"key":"10.1016\/bs.apha.2025.01.015_bib3","series-title":"Vaccination: A history. From Lady Montagu to Genetic Engineering","author":"Bazin","year":"2011"},{"key":"10.1016\/bs.apha.2025.01.015_bib4","article-title":"Augmenting adaptive immunity: Progress and challenges in the quantitative engineering and analysis of adaptive immune receptor repertoires","author":"Brown","year":"2019","journal-title":"ArXiv"},{"issue":"6","key":"10.1016\/bs.apha.2025.01.015_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021289","article-title":"Identification of a highly antigenic linear B cell epitope within Plasmodium vivax apical membrane antigen 1 (AMA-1)","volume":"6","author":"Bueno","year":"2011","journal-title":"PLoS One"},{"issue":"6511","key":"10.1016\/bs.apha.2025.01.015_bib6","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abd4251","article-title":"Distinct conformational states of SARS-CoV-2 spike protein","volume":"369","author":"Cai","year":"2020","journal-title":"Science (New York, N. Y.)"},{"issue":"11","key":"10.1016\/bs.apha.2025.01.015_bib7","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.3390\/ijerph17114140","article-title":"Observed and potential impacts of the COVID-19 pandemic on the environment","volume":"17","author":"Cheval","year":"2020","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"2","key":"10.1016\/bs.apha.2025.01.015_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.6026\/97320630016139","article-title":"2019-nCoV \u2013 Towards a 4th generation vaccine","volume":"16","author":"Chiappelli","year":"2020","journal-title":"Bioinformation"},{"issue":"15","key":"10.1016\/bs.apha.2025.01.015_bib9","first-page":"2210","article-title":"Codon Optimization OnLine (COOL): A web-based multi-objective optimization platform for synthetic gene design","volume":"30","author":"Chin","year":"2014","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"15","key":"10.1016\/bs.apha.2025.01.015_bib10","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting","volume":"384","author":"Dagan","year":"2021","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.apha.2025.01.015_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.628137","article-title":"The limitless future of RNA therapeutics","volume":"9","author":"Damase","year":"2021","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"583","key":"10.1016\/bs.apha.2025.01.015_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe5449","article-title":"Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates","volume":"13","author":"Darricarr\u00e8re","year":"2021","journal-title":"Science Translational Medicine"},{"key":"10.1016\/bs.apha.2025.01.015_bib13","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1016\/j.vaccine.2021.05.098","article-title":"Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models","volume":"39","author":"Dey","year":"2021","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/bs.apha.2025.01.015_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/bfgp\/ely020","article-title":"Vaccine and antibody production in plants: Developments and computational tools","volume":"17","author":"Dubey","year":"2018","journal-title":"Briefings in Functional Genomics"},{"issue":"D1","key":"10.1016\/bs.apha.2025.01.015_bib15","doi-asserted-by":"crossref","first-page":"D1140","DOI":"10.1093\/nar\/gkt1043","article-title":"SAbDab: The structural antibody database","volume":"42","author":"Dunbar","year":"2014","journal-title":"Nucleic Acids Research"},{"issue":"7\u20138","key":"10.1016\/bs.apha.2025.01.015_bib16","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0264-410X(02)00623-0","article-title":"The global value of vaccination","volume":"21","author":"Ehreth","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/bs.apha.2025.01.015_bib17","series-title":"From protein structure to function with bioinformatics","first-page":"57","article-title":"Comparative protein structure modelling","author":"Fiser","year":"2017"},{"key":"10.1016\/bs.apha.2025.01.015_bib18","series-title":"Bioinformatics for vaccinology","first-page":"167","article-title":"Vaccines: Data-driven prediction of binders, epitopes, and immunogenicity","author":"Flower","year":"2008"},{"key":"10.1016\/bs.apha.2025.01.015_bib19","unstructured":"Food and Drug Administration. (2023). Development and Licensure of Vaccines to Prevent COVID-19. Center for Biologics Evaluation and Research, Food and Drug Administration, USA. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/development-and-licensure-vaccines-prevent-covid-19."},{"issue":"5","key":"10.1016\/bs.apha.2025.01.015_bib20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2500\/aap.2021.42.210065","article-title":"The global burden of vaccine-preventable infectious diseases in children less than 5 years of age: Implications for COVID-19 vaccination. How can we do better?","volume":"42","author":"Frenkel","year":"2021","journal-title":"Allergy and Asthma Proceedings"},{"key":"10.1016\/bs.apha.2025.01.015_bib21","series-title":"Clinical immunology","first-page":"223","article-title":"Immunoglobulin function","author":"Greenspan","year":"2019"},{"key":"10.1016\/bs.apha.2025.01.015_bib22","series-title":"A sustainable green future: Perspectives on energy, economy, industry, cities and environment","first-page":"183","article-title":"The importance of vaccines in a sustainable healthy society","author":"G\u00fcl","year":"2023"},{"key":"10.1016\/bs.apha.2025.01.015_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.coviro.2015.03.013","article-title":"Computational tools for epitope vaccine design and evaluation","volume":"11","author":"He","year":"2015","journal-title":"Current Opinion in Virology"},{"key":"10.1016\/bs.apha.2025.01.015_bib24","article-title":"Emerging vaccine informatics","volume":"2010","author":"He","year":"2010","journal-title":"Journal of Biomedicine & Biotechnology"},{"key":"10.1016\/bs.apha.2025.01.015_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030102","article-title":"Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV\/AIDS, tuberculosis, and malaria","volume":"3","author":"Hotez","year":"2006","journal-title":"PLoS Medicine"},{"issue":"20","key":"10.1016\/bs.apha.2025.01.015_bib26","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2\u2014preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/bs.apha.2025.01.015_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nm.4465","article-title":"The role of vaccines in preventing bacterial antimicrobial resistance","volume":"24","author":"Jansen","year":"2018","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2025.01.015_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaci.2012.04.003","article-title":"Adverse reactions to vaccines practice parameter 2012 update","volume":"130","author":"Kelso","year":"2012","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/bs.apha.2025.01.015_bib29","doi-asserted-by":"crossref","unstructured":"Kirnbauer, R., Taub, J., Greenstone, H., Roden, R., Durst, M., Gissmann, L., Schiller, J. T. (1992). Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proceedings of the National Academy of Sciences of the United States of America, 89, 12180\u201312184. https:\/\/doi.org\/10.1073\/pnas.89.24.12180.","DOI":"10.1073\/pnas.89.24.12180"},{"key":"10.1016\/bs.apha.2025.01.015_bib30","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 vaccines in development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.apha.2025.01.015_bib31","doi-asserted-by":"crossref","DOI":"10.3402\/jmahp.v3.27043","article-title":"Role of vaccination in the sustainability of healthcare systems","volume":"3","author":"Largeron","year":"2015","journal-title":"Journal of Market Access & Health Policy"},{"key":"10.1016\/bs.apha.2025.01.015_bib32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nbt.1635","article-title":"Rationalizing the development of live attenuated virus vaccines","volume":"28","author":"Lauring","year":"2010","journal-title":"Nature Biotechnology"},{"key":"10.1016\/bs.apha.2025.01.015_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/prot.25453","article-title":"Antibody side chain conformations are position-dependent","volume":"86","author":"Leem","year":"2018","journal-title":"Proteins"},{"issue":"5","key":"10.1016\/bs.apha.2025.01.015_bib34","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41591-021-01316-7","article-title":"Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine","volume":"27","author":"Levine-Tiefenbrun","year":"2021","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.apha.2025.01.015_bib35","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1021\/acs.bioconjchem.7b00098","article-title":"Ligand characteristics important to avidity interactions of multivalent nanoparticles","volume":"28","author":"Li","year":"2017","journal-title":"Bioconjugate Chemistry"},{"key":"10.1016\/bs.apha.2025.01.015_bib36","series-title":"Development of novel vaccines","first-page":"87","article-title":"Employing live microbes for vaccine delivery","author":"Loessner","year":"2012"},{"issue":"9","key":"10.1016\/bs.apha.2025.01.015_bib37","first-page":"1346","article-title":"Sphinx: Merging knowledge-based and ab initio approaches to improve protein loop prediction","volume":"33","author":"Marks","year":"2017","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"1","key":"10.1016\/bs.apha.2025.01.015_bib38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41591-020-1118-7","article-title":"A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial","volume":"27","author":"Nachbagauer","year":"2021","journal-title":"Nature Medicine"},{"issue":"35","key":"10.1016\/bs.apha.2025.01.015_bib39","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/bs.apha.2025.01.015_bib40","first-page":"1378","article-title":"Sur la vaccination charbonneuse","volume":"92","author":"Pasteur","year":"1881","journal-title":"Comptes Rendus de l'Acad\u00e9mie des Sciences"},{"issue":"42","key":"10.1016\/bs.apha.2025.01.015_bib41","doi-asserted-by":"crossref","first-page":"937","DOI":"10.15585\/mmwr.mm6842a1","article-title":"Global routine vaccination coverage, 2018","volume":"68","author":"Peck","year":"2019","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"5459","key":"10.1016\/bs.apha.2025.01.015_bib42","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.apha.2025.01.015_bib43","first-page":"116","article-title":"Homology modeling and conformational epitope prediction of envelope protein of Alkhumra haemorrhagic fever virus","volume":"9","author":"Poorinmohammad","year":"2015","journal-title":"Journal of Arthropod-Borne Diseases"},{"issue":"4","key":"10.1016\/bs.apha.2025.01.015_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009862","article-title":"Computational immunology meets bioinformatics: The use of prediction tools for molecular binding in the simulation of the immune system","volume":"5","author":"Rapin","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2025.01.015_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.01526","article-title":"Impact of vaccines: Health, economic, and social perspectives","volume":"11","author":"Rodrigues","year":"2020","journal-title":"Frontiers in Microbiology"},{"issue":"2","key":"10.1016\/bs.apha.2025.01.015_bib46","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.celrep.2018.03.061","article-title":"A universal approach to optimize the folding and stability of prefusion-closed HIV-1 envelope trimers","volume":"23","author":"Rutten","year":"2018","journal-title":"Cell Reports"},{"issue":"23","key":"10.1016\/bs.apha.2025.01.015_bib47","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/bs.apha.2025.01.015_bib48","doi-asserted-by":"crossref","unstructured":"Salmon, D. E. (1886). The theory of immunity from contagious diseases. Proceedings of the American Association for the Advancement of Science, 35, 262\u2013266.","DOI":"10.1086\/326003"},{"issue":"1","key":"10.1016\/bs.apha.2025.01.015_bib49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/01652176.2019.1580827","article-title":"Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies \u2013 A comprehensive review","volume":"39","author":"Singh","year":"2019","journal-title":"The Veterinary Quarterly"},{"key":"10.1016\/bs.apha.2025.01.015_bib50","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0167-7799(99)01398-0","article-title":"From genes to protein structure and function: Novel applications of computational approaches in the genomic era","volume":"18","author":"Skolnick","year":"2000","journal-title":"Trends in Biotechnology"},{"key":"10.1016\/bs.apha.2025.01.015_bib51","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.4161\/hv.28077","article-title":"Safety and efficacy of DNA vaccines: Plasmids vs. minicircles","volume":"10","author":"Stenler","year":"2014","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"4","key":"10.1016\/bs.apha.2025.01.015_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8040680","article-title":"Development and applications of viral vectored vaccines to combat zoonotic and emerging public health threats","volume":"8","author":"Vrba","year":"2020","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/bs.apha.2025.01.015_bib53","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1534\/g3.116.036673","article-title":"Genome report: Identification and validation of antigenic proteins from Pajaroellobacter abortibovis using de novo genome sequence assembly and reverse vaccinology","volume":"7","author":"Welly","year":"2017","journal-title":"G3: Genes, Genomes, Genetics"},{"issue":"7","key":"10.1016\/bs.apha.2025.01.015_bib54","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1073\/pnas.0909587107","article-title":"A broad-spectrum antiviral targeting entry of enveloped viruses","volume":"107","author":"Wolf","year":"2010","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/bs.apha.2025.01.015_bib55","unstructured":"World Health Organization (WHO). (2019). Immunization. https:\/\/www.who.int\/news-room\/facts-in-pictures\/detail\/immunization."},{"key":"10.1016\/bs.apha.2025.01.015_bib56","unstructured":"World Health Organization (WHO). (2022). Vaccines and immunization. https:\/\/www.who.int\/health-topics\/vaccines-and-immunization#tab=tab_1."},{"key":"10.1016\/bs.apha.2025.01.015_bib57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.provac.2009.07.005","article-title":"Vaxign: A web-based vaccine target design program for reverse vaccinology","volume":"1","author":"Xiang","year":"2009","journal-title":"Procedia Vaccinology"},{"issue":"1","key":"10.1016\/bs.apha.2025.01.015_bib58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: Promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/bs.apha.2025.01.015_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.dci.2019.103492","article-title":"The effects of CCL3, CCL4, CCL19, and CCL21 as molecular adjuvants on the immune response to VAA DNA vaccine in flounder (Paralichthys olivaceus)","volume":"103","author":"Xu","year":"2020","journal-title":"Developmental & Comparative Immunology"},{"issue":"1","key":"10.1016\/bs.apha.2025.01.015_bib60","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1038\/s41598-019-41285-z","article-title":"Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice","volume":"9","author":"Yee","year":"2019","journal-title":"Scientific reports"}],"container-title":["Advances in Pharmacology","Revolutionizing Drug Discovery:Cutting-Edge Computational Techniques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358925000158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358925000158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T23:08:54Z","timestamp":1743635334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358925000158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443346491"],"references-count":60,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2025.01.015","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}